Clinical trials: sponsored by Samsung Medical Center
Emergencies
Study to Evaluate Satisfaction Using Personal Health Wallet Service
The investigators developed the service showing patient health record altogether which is managed by each hospital separately and recording the patient health information based on mobile application.
- Trial name
- NCT04180618
- Testing
- Personal health wallet service for emergency situation
- Where
- South Korea
- Volunteers
- 1,010 people, healthy volunteers welcome
- Sponsor
- Samsung Medical Center
Recurrent Cystitis
Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract
The purpose of this study is to evaluate the efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract
- Trial name
- NCT02366676
- Testing
- hyaluronic acid and chondroitin sulphate
- Where
- South Korea
- Volunteers
- 105 people
- Sponsor
- Samsung Medical Center
Overactive Bladder, Benign Prostatic Hyperplasia
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
OAB occurs in approximately 50% to 75% of men with BPO and up to 38% of men with BPO continue to suffer from OAB after relief the obstruction.Symptoms of OAB are more bothersome than the voiding complaints of slow stream and…
- Trial name
- NCT00922506
- Testing
- doxazosin plus tolterodine SR
- Where
- South Korea
- Volunteers
- 83 people
- Sponsor
- Samsung Medical Center
Urinary Stress Incontinence
The Comparison of Efficacy Between Electromagnetic Stimulation Therapy and Electromagnetic Stimulation Therapy With Extracorporeal Biofeedback
The aim of this study is to compare the efficacy between Electromagnetic Stimulation therapy and Electromagnetic Stimulation therapy with Extracorporeal Biofeedback in Stress Urinary Incontinence patient.
- Trial name
- NCT02423486
- Testing
- Electromagnetic stimulation therapy (BIOCON-2000), Electromagnetic stimulation therapy with biofeedback
- Where
- South Korea
- Volunteers
- 66 people
- Sponsor
- Samsung Medical Center
Mixed Urinary Incontinence
Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence
Female urinary incontinence (UI) can be caused by pure stress UI (SUI), pure urgency UI (UUI) and mixed SUI and UUI (MUI). Clinically it might not be that easy to separate MUI and SUI.
- Trial name
- NCT01493401
- Testing
- Midurethral slings (MUS)
- Where
- 2 sites in South Korea
- Volunteers
- 137 people
- Sponsor
- Samsung Medical Center
Neurogenic Lower Urinary Tract Dysfunction
Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia
This study is designed to evaluate efficacy and safety of naftopidil in patient with neurogenic lower urinary tract dysfunction not caused by benign prostatic hyperplasia.
- Trial name
- NCT02034604
- Testing
- Naftofidil, Tamsulosin
- Where
- South Korea
- Volunteers
- 194 people
- Sponsor
- Samsung Medical Center
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia
Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH
The purpose of this study is to compare of Efficacy and Safety Between Holmium Laser Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the Lower Urinary Tract Symptoms (LUTS) Secondary to…
- Trial name
- NCT00877669
- Testing
- Transurethral resection of the prostate, Holmium Laser Enucleation of the Prostate
- Where
- South Korea
- Volunteers
- 313 people
- Sponsor
- Samsung Medical Center
Benign Prostatic Hyperplasia (BPH)
Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate
Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate
- Trial name
- NCT03460873
- Testing
- holmium laser enucleation of the prostate
- Where
- South Korea
- Volunteers
- 432 people
- Sponsor
- Samsung Medical Center
Overactive Bladder
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
Nerve growth factor (NGF), prostaglandin E2 (PGE2)and adenosine triphosphate (ATP) levels in urine were reported to increase in patients with overactive bladder (OAB).
- Trial name
- NCT01499069
- Testing
- Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium
- Where
- South Korea
- Volunteers
- 191 people
- Sponsor
- Samsung Medical Center
Bladder Outlet Obstruction, Pressure Flow Study
Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff Test
To provide evidence of promising tests to noninvasively diagnose bladder outlet obstruction (BOO) in men with benign prostatic hyperplasia. 1.
- Trial name
- NCT02031653
- Where
- South Korea
- Volunteers
- 335 people
- Sponsor
- Samsung Medical Center
Benign Prostatic Hyperplasia
Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
This study is designed to investigate the comparison between alpha blocker monotherapy and 5-alpha-reductase inhibitor monotherapy following combination therapy in benign prostatic hyperplasia.
- Trial name
- NCT01301599
- Testing
- combination therapy, alpha blocker monotherapy, 5 alpha reductase inhibitor monotherapy
- Where
- South Korea
- Volunteers
- 308 people
- Sponsor
- Samsung Medical Center
Gait
Effect of Wearable Hip-Assist Robot on Reduction of Cardiopulmonary Metabolic Efficiency in Healthy Adults
The purpose of this study was to investigate the changes in muscle fatigue and respiratory metabolic energy expenditure during walking with wearable hip-assist robot (V3).
- Trial name
- NCT03484624
- Testing
- Treadmill walking
- Where
- South Korea
- Volunteers
- 54 people, healthy volunteers welcome
- Sponsor
- Samsung Medical Center
Locally Advanced Rectal Cancer
Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial
The investigators start this prospective study to evaluate the efficacy of laparoscopic total mesorectal excision after concurrent chemo-radiation therapy with hyperthermia in locally advanced rectal cancer.
- Trial name
- NEOTREAT (NCT02290574)
- Testing
- Hyperthermia with concurrent chemo-radiation therapy
- Where
- South Korea
- Volunteers
- 14 people
- Sponsor
- Samsung Medical Center
Cardiogenic Shock
The Current Status and Clinical Outcomes of Patients With Cardiogenic Shock II
The investigation of patient characteristics and prognostic factors of the patients presented with cardiogenic shock (CS) will guide us to identify the better management strategy for these critically ill patients.
- Trial name
- RESCUE II (NCT04143893)
- Testing
- Mechanical circulatory support, Optimal medical treatment
- Where
- South Korea
- Volunteers
- 1,000 people
- Sponsor
- Samsung Medical Center
Sleep Disorder, Breast Cancer
Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device
The aim of this study is to observe the sleep and activity patterns of pre-menopausal breast cancer patients taking tamoxifen using a wrist-worn internet of things device and questionnaires.
- Trial name
- NCT04116827
- Testing
- Tamoxifen Oral Tablet
- Where
- South Korea
- Volunteers
- 20 people
- Sponsor
- Samsung Medical Center
Healthy Adults, Healthy Aging
Individualized Transcranial Direct Current Stimulation for Gait Function in Healthy Subjects
The purpose of this study is to compare the effects of individualized brain stimulation based on simulation and conventional brain stimulation in healthy adults.
- Trial name
- NCT04030793
- Testing
- Individualized transcranial direct current stimulation, Conventional transcranial direct current stimulation
- Where
- South Korea
- Volunteers
- 19 people, healthy volunteers welcome
- Sponsor
- Samsung Medical Center
Type2 Diabetes Mellitus, Albuminuria
Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
In this multi-center, randomized, double-blind, active-controlled, phase II non-inferiority study, we aimed to test the non-inferiority of evogliptin vs linagliptin in terms of reduction of albuminuria at week 24 from baseline in…
- Conditions
- Type2 Diabetes Mellitus, Albuminuria, Renal Insufficiency
- Trial name
- DA1229 (NCT03667300)
- Testing
- Evogliptin, Linagliptin
- Where
- South Korea
- Volunteers
- 209 people
- Sponsor
- Samsung Medical Center
Stroke
Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke
This study, E-COMPASSII is a phase IV clinical trial designed as a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. This study will enroll 80 subacute stroke patients with severe motor involvement.
- Trial name
- NCT02768571
- Testing
- Cerebrolysin
- Where
- South Korea
- Volunteers
- 80 people
- Sponsor
- Samsung Medical Center
Healthy
Dual Site-Dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Healthy Subjects
The aim of this study is to investigate the effect of dual site-dual channel non-invasive brain stimulation for recovery of language and cognitive function in healthy.
- Trial name
- NCT03486808
- Testing
- IFG stimulation, DLPFC stimulation
- Where
- South Korea
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- Samsung Medical Center
Post-stroke Cognitive Impairment
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Post-stroke Cognitive Impairment
Repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) has been used for the modulation of post-stroke cognitive impairment patients' cognitive function by altering the cortical…
- Trial name
- NCT03647319
- Testing
- High-frequency rTMS on left DLPFC+anodal tDCS on right DLPFC, High-frequency rTMS on left DLPFC+cathodal tDCS on right DLPFC
- Where
- South Korea
- Volunteers
- 29 people
- Sponsor
- Samsung Medical Center